Editorial: New Strategies to Inhibit Cell Death in Myocardial Ischemia-Reperfusion Injury: How to Succeed?
作者信息
Barrère-Lemaire Stéphanie, Piot Christophe, Kumphune Sarawut
机构信息
IGF, Université de Montpellier, CNRS, INSERM, Montpellier, France.
Département de Cardiologie Interventionnelle, Clinique du Millénaire, Montpellier, France.
出版信息
Front Cardiovasc Med. 2022 Jul 4;9:918902. doi: 10.3389/fcvm.2022.918902. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: New Strategies to Inhibit Cell Death in Myocardial Ischemia-Reperfusion Injury: How to Succeed?社论：抑制心肌缺血再灌注损伤中细胞死亡的新策略：如何取得成功？
Front Cardiovasc Med. 2022 Jul 4;9:918902. doi: 10.3389/fcvm.2022.918902. eCollection 2022.
2
Editorial: New strategies to inhibit cell death in myocardial ischemia-reperfusion injury: how to succeed? Volume II.社论：抑制心肌缺血再灌注损伤中细胞死亡的新策略：如何取得成功？第二卷。
Front Cardiovasc Med. 2023 Aug 8;10:1260800. doi: 10.3389/fcvm.2023.1260800. eCollection 2023.
3
Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.心血管危险因素与心肌缺血/再灌注损伤、预处理及后处理之间的相互作用。
Pharmacol Rev. 2007 Dec;59(4):418-58. doi: 10.1124/pr.107.06002. Epub 2007 Nov 29.
4
Novel Findings and Therapeutic Targets on Cardioprotection of Ischemia/ Reperfusion Injury in STEMI.新型发现与治疗靶点：STEMI 缺血/再灌注损伤的心肌保护作用。
Curr Pharm Des. 2019;25(35):3726-3739. doi: 10.2174/1381612825666191105103417.
5
Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus.缺血再灌注损伤、缺血预处理和糖尿病。
J Mol Cell Cardiol. 2016 Feb;91:11-22. doi: 10.1016/j.yjmcc.2015.12.020. Epub 2015 Dec 21.
6
Reperfusion injury in ST-segment elevation myocardial infarction: the final frontier.ST段抬高型心肌梗死中的再灌注损伤：最后的前沿领域。
Coron Artery Dis. 2017 May;28(3):253-262. doi: 10.1097/MCA.0000000000000468.
7
Pharmacological options to protect the aged heart from ischemia and reperfusion injury by targeting the PKA-BK(Ca) signaling pathway.通过靶向蛋白激酶A-大电导钙激活钾通道（PKA-BK(Ca)）信号通路保护老年心脏免受缺血再灌注损伤的药理学选择。
Exp Gerontol. 2014 Aug;56:99-105. doi: 10.1016/j.exger.2014.03.029. Epub 2014 Apr 13.
8
Cardioprotection and ageing.心脏保护与衰老。
Korean J Anesthesiol. 2010 Mar;58(3):223-30. doi: 10.4097/kjae.2010.58.3.223. Epub 2010 Mar 30.
9
Effects of hypoglycemia on myocardial susceptibility to ischemia-reperfusion injury and preconditioning in hearts from rats with and without type 2 diabetes.2 型糖尿病大鼠与非糖尿病大鼠心脏低血糖对缺血再灌注损伤及预处理敏感性的影响。
Cardiovasc Diabetol. 2017 Nov 9;16(1):148. doi: 10.1186/s12933-017-0628-1.
10
Hydrogen sulfide provides cardioprotection against myocardial/ischemia reperfusion injury in the diabetic state through the activation of the RISK pathway.硫化氢通过激活RISK通路，为糖尿病状态下的心肌/缺血再灌注损伤提供心脏保护作用。
Med Gas Res. 2014 Dec 12;4(1):20. doi: 10.1186/s13618-014-0020-0. eCollection 2014.
引用本文的文献
1
Kynurenic acid protects against ischemia/reperfusion injury by modulating apoptosis in cardiomyocytes.犬尿氨酸酸通过调节心肌细胞凋亡来防止缺血/再灌注损伤。
Apoptosis. 2024 Oct;29(9-10):1483-1498. doi: 10.1007/s10495-024-02004-w. Epub 2024 Aug 17.
本文引用的文献
1
Cardiomyocyte ageing and cardioprotection: consensus document from the ESC working groups cell biology of the heart and myocardial function.心肌细胞衰老与心脏保护：欧洲心脏病学会心脏细胞生物学和心肌功能工作组共识文件
Cardiovasc Res. 2020 Sep 1;116(11):1835-1849. doi: 10.1093/cvr/cvaa132.
2
The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs.美国国立心肺血液研究所资助的心脏保护疗法临床前评估联盟（CAESAR）：对小鼠、兔子和猪中假定的梗死挽救干预措施进行严格、准确和可重复评估的新范例。
Circ Res. 2015 Feb 13;116(4):572-86. doi: 10.1161/CIRCRESAHA.116.305462. Epub 2014 Dec 11.
Zotero 插件